FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD). Wu Y, Kumar R, Huang J, Wang M, et al. J Hepatol 2021;74:247-248.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu Y, Kumar R, Huang J, Wang M, et al. FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD). J Hepatol 2021;74:247-248.
PMID: 32994079